Impact of COVID-19 pandemic on key performance indicators in pancreatobiliary endoscopy: prioritise, minimise risk, keep scoping and training

Esmaily, Shiran; Yau, Chia Chuin; Dwarakanath, D; Hancock, John T.; Mitra, Vikramjit

doi:10.1136/flgastro-2020-101701

Cited by 3 publications

(2 citation statements)

References 9 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…During the pandemic era, especially the lockdown period, many previous studies reported a reduction in cases of endoscopic procedure including upper gastrointestinal endoscopy, colonoscopy, and endoscopic ultrasound. The reduction of elective endoscopic procedures was found to have led to the reduction in the malignancy detection rates, 17 , 18 which may have delayed diagnosis and treatment.…”

Section: Discussionmentioning

confidence: 99%

Lockdown period during SARS COVID-19 endemic outbreak in Taiwan did not cause an increase of the complications nor mortality of patients received ERCP: A single center retrospective study

Chang

Hou

et al. 2022

Journal of the Chinese Medical Association

View full text Add to dashboard Cite

Background: Coronavirus disease 2019, known as a widespread, aerosol spreading disease, has affected >549 000 000 people since 2019. During the lockdown period, dramatic reduction of elective endoscopic procedures, including endoscopic retrograde cholangiopancreatography, had been reported worldwide, leading to delayed diagnosis and treatment. Nevertheless, whether patients' hospital stays and complication rate of endoscopic retrograde cholangiopancreatography (ERCP) during the lockdown period were influenced by the pandemic still remains controversial. Methods: Patients who diagnosed with obstructive jaundice and acute cholangitis in the lockdown period, May 16 to July 26, 2021, were compared to the same prepandemic period in 2019. Results: A total of 204 patients in 2019 and 168 patients in 2021 were diagnosed with acute biliary cholangitis or obstructive jaundice, and 82 of the patients in 2019 and 77 patients in 2021 underwent ERCP (p = 0.274). Patients whose quick Sequential Organ Failure Assessment (qSOFA) score was ≥ 2 occurred more during the lockdown period than during the normal period (24/77, 31.1% vs 12/82, 14.6%; p = 0.013). The initial laboratory data, including, total bilirubin (4.12 in 2021 vs 3.08 mg/dL in 2019; p = 0.014), gamma-glutamyl transferase (378 in 2021 vs 261 U/L in 2019; p = 0.009), and alkaline phosphatase (254 in 2021 vs 174 U/L in 2019; p = 0.002) were higher during the lockdown period compared to 2019. Hospital stay was statistically significant longer in the lockdown period (11 days [7.00-22.00] in 2021 vs 8 days in 2019 [6.00-12.00]; p value = 0.02). Multivariate analysis showed that qSOFA ≥ 2 (hazard ratio [HR] = 3.837, 95% confidence interval [CI] = 1.471-10.003; p = 0.006), and malignant etiology (HR = 2.932, 95% CI = 1.271-6.765; p = 0.012) were the statistically significant factors for a prolonged hospital stay, which was defined as hospital stay >21 days. ERCP-related complications and mortality rate were not statistically different between the two periods. Conclusion: Patients from May 16 to July 26, 2021, the lockdown period, had longer hospital stays and higher biliary tract enzyme levels, which indicated more severe disease. Nevertheless, ERCP could be safely and successfully performed even during the medical level 3 alert lockdown period without causing an increase in procedure-related complications and mortality.

show abstract

Section: Discussionmentioning

confidence: 99%

Lockdown period during SARS COVID-19 endemic outbreak in Taiwan did not cause an increase of the complications nor mortality of patients received ERCP: A single center retrospective study

Chang

Hou

et al. 2022

Journal of the Chinese Medical Association

View full text Add to dashboard Cite

show abstract

“…One of the first studies to assess the impact of COVID-19 on KPIs [44], analyzed the impact of COVID-19 on pancreato-biliary endoscopy-related KPIs. However, limited research was found to assess the HCOs -related KPIs at COVID-19 in general.…”

Section: Kpis During Covid-19 Pandemicmentioning

confidence: 99%

A Systematic Review: The Dimensions utilized in the Performance Evaluation of Healthcare- An Implication during the COVID-19 Pandemic

Amer

Hammoud

Khatatbeh

et al. 2021

Preprint

View full text Add to dashboard Cite

This systematic review aims to identify the Key Performance Indicators (KPIs) which are the most frequently used and important in the Performance Evaluation (PE) of Health Care Organizations (HCOs). Also, it aimed to analyze the resulted Balanced Scorecard (BSC) dimensions during the Coronavirus Disease 2019 (COVID-19) era. This systematic review was prepared according to PRISMA guidelines. PubMed, Embase, Cochrane, and Google Scholar databases, as well as Google search engine, were inspected to find all implementations of BSC at HCOs until 20 September 2020. The Risk of Bias (RoB) was assessed for each included article. The eligible studies were 33, in which 36 BSC implementations were identified. The categorization and re-grouping of the 797 KPIs resulted in 13 major-dimensions: The financial, efficiency and effectiveness, availability and quality of supplies and services, managerial tasks, Health Care Workers (HCWs) scientific development error-free and safety, the time, HCW-centeredness, patient-centeredness, technology and information system, community care and reputation, HCO building, and the communication. Under them, 45 sub-dimension were identified. The high RoB in most implementations was due to the selection bias. None of the 36 BSC implementations was utilized during the COVID-19 pandemic. This review solves the dilemma of categorization differences among BSC implementations, which in turn will improve the data sharing and comparability among studies. A modification for the BSC design to include external and managerial perspectives is required. However, a lack of a comprehensive PE for HCOs during the pandemic was observed, so the resulted dimensions and KPIs are recommended for planning, monitoring, evaluation, and continuous improvement of HCOs. Many dimensions were negatively influenced by the pandemic. However, some dimensions still need further investigation. BSC dimensions have an essential role in tackling the COVID-19 pandemic and will help the health care managers to mitigate its consequences on HCOs.

show abstract

Real-life patency of plastic biliary stents in the pandemic era: is stent removal after 6 months safe and effective?

Freitas

Capela

Silva

et al. 2023

Scandinavian Journal of Gastroenterology

View full text Add to dashboard Cite

Impact of COVID-19 pandemic on key performance indicators in pancreatobiliary endoscopy: prioritise, minimise risk, keep scoping and training

Cited by 3 publications

References 9 publications

Lockdown period during SARS COVID-19 endemic outbreak in Taiwan did not cause an increase of the complications nor mortality of patients received ERCP: A single center retrospective study

Lockdown period during SARS COVID-19 endemic outbreak in Taiwan did not cause an increase of the complications nor mortality of patients received ERCP: A single center retrospective study

A Systematic Review: The Dimensions utilized in the Performance Evaluation of Healthcare- An Implication during the COVID-19 Pandemic

Real-life patency of plastic biliary stents in the pandemic era: is stent removal after 6 months safe and effective?

Contact Info

Product

Resources

About